https://www.selleckchem.com/pr....oducts/Streptozotoci
Drug-related adverse events were less common with rifampin than isoniazid among people living with HIV (risk difference -2.1%, 95%CI -5.9 to 1.6). This was consistent for others except people with renal failure or on immunosuppressants (2.1%, 95%CI -7.2 to 11.3). Tuberculosis incidence was similar among people receiving rifampin or isoniazid. Among participants receiving rifampin living with HIV, incidence was comparable to those with no health condition (rate difference 4.1 per 1000 person-years, 95%CI -6.4 to 14.7). Rifampin ap
Like
Comment
Share
